Table 3.
Adjusted odds of full adherence
| Regression covariate | Adjusted odds ratio† (95% CI) |
|---|---|
| Trial arm | |
| MDA | Ref. |
| FMDA | 2.59** (1.31–5.15) |
| Person responding to adherence questions | |
| On behalf of someone who is absent | Ref. |
| On behalf of child younger than 10 years | 1.50*** (1.43–1.59) |
| Self-response | 2.00*** (1.92–2.09) |
| Rapid diagnostic test positive | 1.30*** (1.22–1.39) |
| Age category (years) | |
| < 5 | Ref. |
| 5–15 | 1.00 (0.96–1.05) |
| > 15 | 0.80*** (0.75–0.85) |
| First treatment directly observed therapy by community health worker | 1.35*** (1.28–1.42) |
| Heard MDA sensitization messages | 1.17*** (1.12–1.22) |
| Gender (female) | 1.03 (1.00–1.06) |
| Fever in the previous 2 weeks | 0.85*** (0.78–0.93) |
| Total, N | 170,453 |
fMDA = focal MDA; MDA = mass drug administration.
* P < 0.05, **P < 0.01, ***P < 0.001.
†
Random effects for trial cluster and MDA rounds.